Cannabis

Research into biomarkers to identify concussion and differentiate ischemic stroke from intracerebral hemorrhage topped Healio Neurology’s coverage in March. Plus: cannabis use, neuroplasticity after stroke and Lewy body dementia.

Patients self-reported varying opinions on cannabis use and its efficacy in alleviating the symptoms of Parkinson’s disease, according to a study published in NPJ Parkinson’s Disease that characterized patterns of use among the population.

Adolescents who vape cannabis have greater risk for lung injury and respiratory symptoms compared with those who smoke or vape other substances, according to findings published in the Journal of Adolescent Health.

Cannabis use ”significantly contributes” to the prevalence of medication overuse headache among patients with chronic migraine, according to study results scheduled for presentation at the American Academy of Neurology Annual Meeting.

Access to medical and recreational cannabis dispensaries was associated with reductions in opioid-related mortality in counties where cannabis is legal in the United States, according to research published in BMJ.

A survey revealed that many patients with allergy and asthma who use cannabis — including those with uncontrolled asthma — smoke or vape cannabis rather than use edibles or tinctures.

Cannabis use disorder was associated with self-harm, all-cause mortality, unintentional overdose death and homicide among youth with mood disorders, according to a study published in JAMA Pediatrics.

Health care conferences around the world looked completely different in 2020 as the COVID-19 pandemic forced organizations to conduct virtual meetings.

Patients who used cannabis and underwent opioid agonist therapy in Vancouver had a significantly lower risk of being exposed to fentanyl, according to a study published in Drug and Alcohol Dependence.

Women who use cannabis may be less likely to conceive than women who do not, according to research published in Human Reproduction.